Video Experimental Relacionado
Updated: Sep 8, 2025
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.0K
Una herramienta basada en la estructura para interpretar la importancia de las mutaciones de la quinasa en la
Amith Rangarajan1, Ilona Sviezhentseva2, Emma Gunderson3
1Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, United States.
Frontiers in oncology
|August 20, 2025
Resumen
Este estudio introduce una nueva base de datos que utiliza estructuras de proteínas en 3D para analizar las mutaciones del cáncer. Esta herramienta ayuda a estandarizar el análisis de la variante de significado desconocido (VUS), avanzando en la terapia personalizada del cáncer.
Área de la Ciencia:
- Bioinformática estructural
- La genómica
- Terapia contra el cáncer
Sus antecedentes:
- El análisis clínico de variantes de importancia desconocida (VUS) de secuenciación de próxima generación (NGS) es manual y requiere mucho tiempo.
- Hay una necesidad crítica de herramientas estandarizadas para interpretar los VUS en entornos clínicos.
- Los avances en los datos de estructura de proteínas (Banco de datos de proteínas, AlphaFold) ofrecen nuevas oportunidades para el análisis de variantes.
Objetivo del estudio:
- Desarrollar un método estandarizado para analizar las VUS de quinasa utilizando información estructural.
- Crear una base de datos de mutaciones estructuralmente alineadas y funcionalmente anotadas.
- Ayudar en la identificación de mutaciones activadoras y comprender los mecanismos de activación de la quinasa.
Principales métodos:
- Mapeó miles de mutaciones de mal sentido del Catálogo de Mutaciones Somáticas en Cáncer (COSMIC) en 48 estructuras de receptor tirosina quinasa (RTK).
- Se agruparon mutaciones activadoras conocidas y VUS basadas en la proximidad estructural 3D.
- Se utilizaron modelos basados en células para validar la identificación de mutaciones activadoras.
Principales resultados:
- Desarrolló una base de datos de mutaciones estructuralmente alineadas y anotadas para evaluar las VUS de quinasa.
- Creado un sitio web fácil de usar para ingresar mutaciones de quinasa y recuperar mutaciones estructuralmente análogas y anotaciones funcionales.
- Demostró la utilidad del recurso para identificar mutaciones activadoras y proporcionar información sobre la regulación de la quinasa.
Conclusiones:
- La base de datos desarrollada sirve como una herramienta valiosa para la predicción funcional de los VUS de la quinasa.
- Se espera que este recurso mejore los flujos de trabajo actuales de análisis de SGN.
- Los hallazgos tienen implicaciones clínicas significativas para guiar las recomendaciones de terapia personalizada contra el cáncer.
Palabras clave:
el cáncerLas quinasasPatología molecularsecuenciación de próxima generaciónBiología estructuraltratamiento dirigidovariantes de importancia desconocidaMás Videos Relacionados
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.5K
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
8.0K
Videos de Conceptos Relacionados
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
01:19Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K